The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of ...

US biotech major Biogen and Chicago, Canada-based Vanqua Bio today announced a license agreement granting Biogen exclusive ...

San Diego-based inflammatory diseases specialist Ventyx Biosciences announced positive results from its Phase II study of ...

Japan’s Mitsubishi Tanabe Pharma (MTPC) yesterday announced that the US Food and Drug Administration (FDA) has issued a ...

US clinical-stage biotech Tango Therapeutics has announced the pricing of an underwritten offering of 21,023,337 shares of ...

French pharma major Sanofi (Euronext: SAN) reported third-quarter 2025 revenue of 12.4 billion euros ($13.2 billion), up 7% ...

The Association for Accessible Medicines (AAM) has filed for a federal injunction to prevent Connecticut from enforcing a new ...

French biotech Abolis Biotechnologies has signed a strategic partnership with EUROAPI (EPA: EAPI) to develop microbial ...

A Swiss biotech company that applies quantum-informed science, causal biology, multi-omics and proprietary AI to early-stage ...

Elixion Biotech has emerged from stealth with a breakthrough that it claims could reshape early-stage drug discovery.

Research from GlobalData highlights the strength of Novartis' (NOVN: VX) position in IgA nephropathy (IgAN), following strong ...

Q3 2025 report reveals that the biotech industry witnessed a 70.9% increase in total venture financing deal value from $1.8 billion in second-quarter 2025 to $3.1 billion in third-quarter 2025.